Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
Also known as: Polyarticular Juvenile Idiopathic Arthritis / Polyarticular Course Juvenile Idiopathic Arthritis / Polyarticular juvenile idiopathic arthritis (disorder) / Juvenile arthritis, unspecified / Arthritis, Juvenile / Juvenile arthritis / Juvenile idiopathic arthritis / Juvenile idiopathic arthritis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01281 | Abatacept | A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease. |
DB00051 | Adalimumab | A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. |
DB00005 | Etanercept | A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. |
DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
DB08895 | Tofacitinib | A Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00051 | Adalimumab | 1 | Completed | 1 |
DB12645 | Givinostat | 2 | Terminated | 1 |
DB08904 | Certolizumab pegol | 3 | Completed | 1 |
DB06273 | Tocilizumab | 3 | Completed | 1 |
DB08895 | Tofacitinib | Not Available | Active Not Recruiting | 1 |